PASTEUR Act of 2021
Latest action · Aug 2, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJun 16, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
The Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 or the PASTEUR Act of 2021
This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions.
A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.
Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.
HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.
Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.
Cosponsors 65
Members who signed on, in the order they did. Signatures ran from Jun 16, 2021 to Sep 13, 2022, with 1 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-GA | A. Drew Ferguson IV | Original | Jun 16, 2021 |
| R-OH | Brad R. Wenstrup | Aug 24, 2021 | |
| R-PA | Brian K. Fitzpatrick | Aug 24, 2021 | |
| D-MA | Jake Auchincloss | Aug 24, 2021 | |
| D-CA | Tony Cárdenas | Aug 24, 2021 | |
| R-GA | Earl L. "Buddy" Carter | Oct 19, 2021 | |
| D-WA | Kim Schrier | Oct 19, 2021 | |
| R-UT | Chris Stewart | Oct 25, 2021 | |
| D-NC | Deborah K. Ross | Oct 26, 2021 | |
| R-FL | Maria Elvira Salazar | Oct 26, 2021 | |
| R-TX | Michael C. Burgess | Oct 26, 2021 | |
| D-IL | Sean Casten | Oct 26, 2021 | |
| D-CO | Diana DeGette | Nov 3, 2021 | |
| R-MI | Fred Upton | Nov 3, 2021 | |
| R-NE | Adrian Smith | Nov 17, 2021 |
Actions 6
Everything that happened, newest first.
- Aug 2, 2021Referred to the Subcommittee on Health.
- Jun 17, 2021Referred to the Subcommittee on Health.
- Jun 17, 2021Referred to the Subcommittee on Oversight, Management, and Accountability.
- Jun 16, 2021Introduced in House
- Jun 16, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, Armed Services, the Judiciary, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2076 | PASTEUR Act of 2021 | Identical bill | Jun 16, 2021 |
| HR 6000 | Cures 2.0 Act | Related bill | Jan 4, 2022 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Advisory bodies
- Appropriations
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Executive agency funding and structure
- Government information and archives
- Government studies and investigations
- Health
- Health programs administration and funding
- Indian social and development programs
- Infectious and parasitic diseases
- Manufacturing
- Medicaid
- Medicare
- Military medicine
- Minority health
- Prescription drugs
- Public contracts and procurement
- Veterans' medical care
- World health
Text 1
Each version as it was printed, newest first.
- Jun 16, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.